Suchen
OPKO Health Inc
OPKZur Watchlist hinzufügen
1.630USD
-0.070-4.12%
Trading geöffnet 09/24, 12:00（ET）
1.22BMarktkapitalisierung
VerlustKGV TTM
Über OPKO Health Inc Unternehmen
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
OPKO Health Inc Profil
BörsenkürzelOPK
Name des UnternehmensOPKO Health Inc
IPO-datumNov 02, 1995
CEOCruz (Tony F)
Anzahl der mitarbeiter2997
WertpapierartOrdinary Share
GeschäftsjahresendeNov 02
Addresse- -
Stadt- -
BörseNASDAQ OMX - NASDAQ BASIC
Land- -
Postleitzahl- -
Telefon- -
Website- -
BörsenkürzelOPK
IPO-datumNov 02, 1995
CEOCruz (Tony F)
Führungskräfte von OPKO Health Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Subbarao V. Uppaluri, Ph.D.
Dr. Subbarao V. Uppaluri, Ph.D.
Independent Director
Independent Director
3.16M
--
Dr. Subbarao V. Uppaluri, Ph.D.
Dr. Subbarao V. Uppaluri, Ph.D.
Independent Director
Independent Director
3.16M
--
Dr. Subbarao V. Uppaluri, Ph.D.
Dr. Subbarao V. Uppaluri, Ph.D.
Independent Director
Independent Director
3.16M
--
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
125.90K
-42.31%
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
125.90K
-42.31%
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
125.90K
-42.31%
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
103.33K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Subbarao V. Uppaluri, Ph.D.
Dr. Subbarao V. Uppaluri, Ph.D.
Independent Director
Independent Director
3.16M
--
Dr. Subbarao V. Uppaluri, Ph.D.
Dr. Subbarao V. Uppaluri, Ph.D.
Independent Director
Independent Director
3.16M
--
Dr. Subbarao V. Uppaluri, Ph.D.
Dr. Subbarao V. Uppaluri, Ph.D.
Independent Director
Independent Director
3.16M
--
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
125.90K
-42.31%
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
125.90K
-42.31%
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
125.90K
-42.31%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von OPKO Health Inc?
Die fünf größten Anteilseigner von OPKO Health Inc sind: Dr. Subbarao V. Uppaluri, Ph.D.
Wie viele Institutionen halten Anteile an OPKO Health Inc (OPK)?
Mit Stand vom 2026Q1 halten 451 Institutionen Anteile an OPKO Health Inc, mit einem Gesamtmarktwert von etwa 236.82M, was 31.36% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -9382421.00 gestiegen.
Was ist die größte Einnahmequelle von OPKO Health Inc?
Am 2026Q1 erzielte das Geschäft mit Health Insurers für OPKO Health Inc den höchsten Umsatz in Höhe von 49.99M, was 67.06% des Gesamtumsatzes entspricht.